First report on the targeted therapy of an IDH1-mutated Cholangiocarcinoma in a patient with Maffucci syndrome

被引：0
|
作者：
Peters, M. [1 ]
Lessel, D. [2 ]
Bernreuther, C. [3 ]
Iglauer, P. [3 ]
Heukamp, L. [4 ]
Velthaus, J. -L. [1 ]
Bokemeyer, C. [1 ]
Sonja, L. [1 ]
Volk, A. [2 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 2, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany
[3] Univ Klinikum Hamburg Eppendorf UKE, Hamburg, Germany
[4] Inst Hamatopathol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
426
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [1] IDH1-MUTATED PITUITARY ADENOMA CHALLENGES TRADITIONAL CHARACTERIZATION OF MAFFUCCI SYNDROME
    Hong, Christopher
    Hao, Shuyu
    Feng, Jie
    Yang, Chunzhang
    Chittiboina, Prashant
    Zhang, Junting
    Zhuang, Zhengping
    NEURO-ONCOLOGY, 2015, 17 : 7 - 7
  • [2] Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions
    Lavacchi, Daniele
    Caliman, Enrico
    Rossi, Gemma
    Buttitta, Eleonora
    Botteri, Cristina
    Fancelli, Sara
    Pellegrini, Elisa
    Roviello, Giandomenico
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    PHARMACOLOGY & THERAPEUTICS, 2022, 237
  • [3] An IDH1-mutated primary gliosarcoma: case report
    Hsieh, Jason K.
    Hong, Christopher S.
    Manjila, Sunil
    Cohen, Mark L.
    Lo, Simon
    Rogers, Lisa
    Sloan, Andrew E.
    JOURNAL OF NEUROSURGERY, 2017, 126 (02) : 476 - 480
  • [4] CHARACTERISTICS OF THE TUMOR MICROENVIRONMENT IN IDH1-MUTATED CHOLANGIOCARCINOMA PATIENTS FROM CLARIDHY TRIAL
    Saatcioglu, H. Duygu
    Valle, Juan
    Macarulla, Teresa
    Javle, Milind
    Oh, Do-Youn
    Goyal, Lipika
    Conway, Jake
    Iyer, Janani
    Najdawi, Fedaa
    Shah, Chintan
    Gliser, Camelia
    Pandya, Susan
    Daigle, Scott
    Abou-Alfa, Ghassan
    Kelley, Robin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A576 - A577
  • [5] Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters
    Rimini, Margherita
    Loi, Eleonora
    Fabregat-Franco, Carles
    Burgio, Valentina
    Lonardi, Sara
    Niger, Monica
    Scartozzi, Mario
    Raposelli, Ilario G.
    Aprile, Giuseppe
    Ratti, Francesca
    Pedica, Federica
    Verdaguer, Helena
    Rizzato, Mario
    Nichetti, Federico
    Lai, Eleonora
    Cappetta, Alessandro
    Macarulla, Teresa
    Fassan, Matteo
    De Braud, Filippo
    Pretta, Andrea
    Simionato, Francesca
    De Cobelli, Francesco
    Aldrighetti, Luca
    Fornaro, Lorenzo
    Cascinu, Stefano
    Patrizia, Zavattari
    Casadei-Gardini, Andrea
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 299 - 310
  • [6] Ivosidenib and Azacitidine in IDH1-Mutated AML REPLY
    Montesinos, Pau
    de Botton, Stephane
    Doehner, Hartmut
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (26): : 2536 - 2537
  • [7] Blockade of Glutathione Metabolism in IDH1-Mutated Glioma
    Tang, Xiaoying
    Fu, Xiao
    Liu, Yang
    Yu, Di
    Cai, Sabrina J.
    Yang, Chunzhang
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 221 - 230
  • [8] Lenvatinib demonstrates enhanced efficacy in IDH1-mutated cholangiocarcinoma with hyper vascular features on abdominal CT
    Wu, W-C
    Chen, M-H
    Chiang, N-J.
    ANNALS OF ONCOLOGY, 2024, 35 : S1461 - S1461
  • [9] Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia
    Sahin, Ilyas
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (12): : 1186 - 1186
  • [10] Y Clustering analysis identified three IDH1-mutated intrahepatic cholangiocarcinoma's clusters with prognostic significance
    Rimini, M.
    Loi, E.
    Fabregat, C.
    Burgio, V.
    Lonardi, S.
    Niger, M.
    Scartozzi, M.
    Rapposelli, I.
    Aprile, G.
    Ratti, F.
    Pedica, F.
    Macarulla, T.
    De Cobelli, F.
    Aldrighetti, L.
    Fornaro, L.
    Cascinu, S.
    Zavattari, P.
    Casadei-Gardini, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S295 - S295
12345